Annual Wearable Intelligence Review
Your Year in Review
Alex's 12 Months with WWG
6 January 2025 – 4 January 2026 · Wearable Wellness Guide
Attestation. This Review is a wellness interpretation of consumer wearable data. It is not a diagnosis, not a treatment plan, and not a substitute for care from your own doctor. The Year-in-Health Narrative that follows was written personally by the WWG Medical Director. At this tier that authorship is not delegable and has not been delegated.
Year-in-Health Narrative
Dear Alex,
This document exists because you stayed. I want to open with that, plainly, because it is not a formality. Three of the findings in this Review were structurally impossible to produce in March, or June, or September. They required twelve consecutive months of physician-reviewed data, and there is no shortcut to them — not a better device, not a smarter algorithm, not a more expensive subscription. Only the year.
Let me tell you what your year showed.
You began in January with a stable, ordinary baseline — HRV around 48 ms, resting heart rate 56, seven and a quarter hours of sleep at 90 per cent efficiency, roughly 8,700 steps a day. You closed the year at 56 ms, 51 bpm, 7.7 hours at 93 per cent, and 10,100 steps. Every one of those moved in the favourable direction, and none of them moved dramatically in any single week. That is what a real year of change looks like: not a transformation, but a slow accumulation you would not have noticed from inside it.
Your first quarter was the hardest, and it taught us the most. February's trip cost you nearly three standard deviations of HRV. March's product launch produced a textbook Sleep Debt Cascade — sleep opportunity compressing first, efficiency following, recovery capacity declining behind both. And in cycle 11 your running volume rose while every recovery marker you had was falling, which is the Training Overreach Signal. You felt fine. Your data disagreed. You reduced your volume by about a third on Dr. Kapoor's recommendation and your HRV moved 43 to 47 to 51 in three weeks.
I have read a great many first quarters. Yours is unusual not because the numbers were good — they were mixed — but because you acted on information that contradicted how you felt. Almost everything that followed traces back to that.
Your second quarter was the turn. Cycle 20 added your Garmin, and I want to be transparent about what happened next, because it is the kind of thing most services would quietly smooth over. Your two devices disagreed. Garmin's overnight HRV readings ran roughly six to nine milliseconds below Oura's through cycles 20 to 26. Neither was wrong. They sample differently, and comparing them directly is a category error. We kept Oura as your primary HRV source for the entire year specifically so that your December numbers remain comparable to your January ones, and used Garmin for daytime activity and running. Your baseline is only meaningful if it is measured the same way throughout, and protecting that mattered more than adding a second opinion.
Your third quarter was consolidation. Cycles 30, 31 and 32 each carried a Holding Steady designation, and under our framework a third consecutive steady cycle is relabelled Optimising — because sustained stability at an improved level is not the same thing as stagnation, and it should not read like it. That was cycle 32. Your summer months are the quietest stretch in your entire record, and they are also where your largest gains consolidated.
Your fourth quarter held. December is where most subscribers give back part of their year. You did not. Your December sleep stayed between 7.5 and 7.7 hours, your efficiency held at 92 to 93 per cent, and your final travel week in cycle 51 cost you two days of recovery rather than five.
Which brings me to the finding that only a year could produce. You travelled ten times this year. In February, your recovery took about five days. In December, it took two. That decline is gradual, monotonic, and completely invisible at any shorter horizon — no weekly report shows it, no monthly summary contains enough trips, and no single quarter holds more than three. It required all ten instances laid end to end. Your body did not become better at travelling; the evidence suggests you became better at recovering, and the improvement was slow enough that you could not have felt it happening.
Now the limits, which matter as much as the findings. This is your first year, so there is no year-over-year comparison in this document — that section does not exist yet, and I would rather it be absent than padded. Everything here rests on consumer wearable data, which is not clinical-grade: your sleep-efficiency figures in particular are directional rather than precise, because consumer sleep-staging is meaningfully less accurate than a clinical sleep study. Nothing in this Review is a diagnosis, and nothing in your year suggested anything requiring medical attention. The improvements described are wellness signals, not clinical outcomes, and I will not overstate them.
What I would carry into next year. Your data has a consistent shape: when demand rises, sleep opportunity is the first thing you surrender, and everything else follows it down. That was true in March and it was true, more mildly, in October. It is the single most reliable pattern in fifty-two weeks of your record, and it is the one worth watching most closely — because it is also the one you have already proven you can change.
Thank you for the year. Genuinely.
Dr. R. Menon, MBBS
Medical Director, Wearable Wellness Guide — illustrative name, sample report
Year-in-Health Narrative: 1,047 words. Annual enforced range 1,000–1,200 words. This section is personally authored by the Medical Director; at Tier 4 this authorship is non-delegable.
12-Month Baseline Evolution Chart
Sparkline set — one line per metric, 52 weekly points each, with the personal baseline band shaded. Reference values marked at weeks 1, 12, 26, 39 and 52.
Heart Rate Variability (ms)
Quarterly means 46.4 → 49.5 → 52.4 → 54.9 · year 50.8 · week 1 → week 52: +11 ms
Resting Heart Rate (bpm)
Quarterly means 56.6 → 54.3 → 52.7 → 51.5 · year 53.8 · week 1 → week 52: −7 bpm (lower is the favourable direction)
Sleep Duration (hours)
Quarterly means 7.0 → 7.3 → 7.5 → 7.7 · year 7.4 · +48 minutes per night
Sleep Efficiency (%)
Quarterly means 88.8 → 90.5 → 91.9 → 92.9 · year 91.0 · +5 percentage points — read directionally, see the reliability rating below
Step Count (per day)
Quarterly means 8,880 → 9,500 → 9,850 → 10,110 · year 9,580 · +1,900 steps per day
Across all five: every metric improved monotonically by quarter. The visible sawtooth in each line corresponds to your ten travel weeks — and the amplitude of that sawtooth narrows across the year, which is the visual form of the finding on page 5.
| Metric | Week 1 | Month 3 | Month 6 | Month 9 | Week 52 | Change |
|---|---|---|---|---|---|---|
| HRV | 45 ms | 47 | 53 | 54 | 56 ms | +11 |
| Resting HR | 58 bpm | 57 | 52 | 52 | 51 bpm | −7 |
| Sleep duration | 6.9 h | 7.0 | 7.6 | 7.6 | 7.7 h | +0.8 |
| Sleep efficiency | 88 % | 89 | 92 | 93 | 93 % | +5 |
| Steps | 8,200 | 8,500 | 9,700 | 10,100 | 10,100 | +1,900 |
Full-Year Wellness Trajectory
| Quarter | Trajectory |
|---|---|
| Q1 — cycles 1–13 | → Holding Steady |
| Q2 — cycles 14–26 | ↑ Trending Well |
| Q3 — cycles 27–39 | ↑ Trending Well |
| Q4 — cycles 40–52 | ↑ Trending Well |
| Full year | ↑ Trending Well |
Cycles 30, 31 and 32 each carried a Holding Steady weekly designation. Under the WWG framework, a third consecutive steady cycle is relabelled Optimising — sustained stability at an improved level, not stagnation. Cycle 32 was designated accordingly.
Device Reliability Rating — Full Year
Recommendation Retrospective
Every recommendation made across your year, and what happened with each.
Quarter 1
| # | Recommendation | Cycle | Outcome | Metric response |
|---|---|---|---|---|
| 1 | Anchor weeknight lights-out within 30 min of usual | 5 | Partial | Efficiency 86 → 90 % (cycles 6–8); did not survive travel |
| 2 | Return to walking routine within 24 h of landing | 7 | Implemented | Steps 8,800 → 9,000 (cycles 7–8) |
| 3 | Protect 7-hour sleep opportunity on 5+ nights during launch | 10 | Deferred then implemented from cycle 12 | Sleep 6.3 → 7.0 → 7.4 h |
| 4 | Reduce weekly running volume by ~⅓ until recovery stabilises | 11 | Implemented & sustained | HRV 43 → 47 → 51 ms; RHR 59 → 54 bpm |
Quarter 2
| # | Recommendation | Cycle | Outcome | Metric response |
|---|---|---|---|---|
| 5 | Travel Sleep Anchor — lights-out within 30 min on travel nights | 16 | Implemented from cycle 17 | Travel-week efficiency 87 → 89 (c20) → 90 % (c24) |
| 6 | Two low-intensity days after any event week | 16 | Implemented | HRV cycle 17 = 51 ms |
| 7 | Move longer runs to non-travel weeks where schedule allows | 22 | Partial — often not schedulable | No isolable metric response |
Quarter 3
| # | Recommendation | Cycle | Outcome | Metric response |
|---|---|---|---|---|
| 8 | Add a 10-minute walk on arrival day of every trip | 28 | Implemented | Travel-week steps held above 9,300 |
| 9 | Keep weekend and weekday wake times within one hour | 31 | Implemented | Efficiency 92 → 93 % |
| 10 | Hold evening caffeine cut-off at 2 p.m. through autumn | 36 | Implemented | Efficiency held 92–93 % through cycles 37–39 despite rising demand |
Quarter 4
| # | Recommendation | Cycle | Outcome | Metric response |
|---|---|---|---|---|
| 11 | Keep the arrival-day walk on all trips, including one-nighters | 42 | Implemented | Cycle 42 recovery: 2 days |
| 12 | Protect the 7.5-hour sleep opportunity across December | 45 | Implemented | December sleep 7.5–7.7 h |
| 13 | Carry the same wind-down routine into the holiday weeks | 49 | Implemented | Cycle 51 travel dip 2 days; recovered by cycle 52 |
Year totals
Implemented in full
10
Partially implemented
2
Deferred, then implemented
1
Analysis
Ten of thirteen implemented in full is a high rate, and the three that were not divide instructively.
Recommendations 1 and 7 share a failure mode: both asked for consistency in circumstances where your control was lowest — travel weeks, and a work calendar you do not set. Recommendation 5 succeeded where recommendation 1 failed, and the difference was not effort. It was that recommendation 5 moved the decision to before you left home, when you still had control, rather than asking you to exercise judgement on the road. That is a lesson about how recommendations should be built, and it changed how your later ones were written.
Recommendation 3 is the one I would not remove from this table. You did not protect your sleep during your March launch, your data recorded the cost, and you implemented it afterwards. A retrospective that only listed successes would be a marketing document rather than a clinical one.
The strongest metric responses of your year — recommendations 4, 5 and 11 — all share one property: a single concrete action attached to an unmissable trigger. Landing. Leaving home. A specific weekly volume. None of them asked you to remember anything in the moment.
Full-year retrospective analysis authored by Dr. R. Menon, Medical Director. AI assembled the audit data; the analysis is physician-authored.
What Only a Year Reveals
Three findings in this Review could not have appeared in any shorter document. Here they are, with an honest statement of how strongly each is supported.
1. Your travel recovery window shortened from about five days to about two
This is the central finding of your year.
Days to recovery after each trip
Ten trips across twelve months · descending step chart
| Trip | Cycle | Month | Days to return to your HRV range |
|---|---|---|---|
| 1 | 6 | February | ~5 days |
| 2 | 15 | April | ~5 days |
| 3 | 20 | May | ~4 days |
| 4 | 24 | June | ~4 days |
| 5 | 29 | July | ~3 days |
| 6 | 33 | August | ~3 days |
| 7 | 38 | September | ~3 days |
| 8 | 42 | October | ~2 days |
| 9 | 47 | November | ~2 days |
| 10 | 51 | December | ~2 days |
The depth of each trip-week dip narrowed alongside it: your travel-week HRV sat about 6 ms below its surrounding weeks in February and about 2 ms below by December.
Why no shorter report could show this. A weekly report contains one trip. A monthly summary contains at most one. A quarterly letter contains two or three — enough to notice a difference, not enough to distinguish a trend from noise. Ten instances across twelve months is the minimum that makes the decline legible, and this is the first document in your subscription that holds all ten.
Strength of evidence: good. Ten instances, monotonic decline, consistent with the recommendations implemented in cycles 16, 28 and 42. It is not proof of causation — your fitness, your sleep habits and the seasons all changed across the same year — but the pattern is real and it is yours.
2. Your sleep opportunity is the first thing to go under demand — every time
This appeared as a provisional observation in your Quarter 1 letter. Across the full year it held. In March, in October, and in two milder instances in June and September, the same ordering appeared: sleep opportunity compressed first, sleep efficiency declined behind it, HRV declined last.
Strength of evidence: strong. Four instances across four quarters, with the same ordering each time and no counter-example in fifty-two cycles. This is the most reliable pattern in your record.
What it means practically: your sleep duration is the earliest available warning signal you have. It moves before your recovery markers do.
3. Your winter activity floor is seasonal, not behavioural
Your step count sat lowest in cycles 1 and 10 — both mid-winter — and highest across July and August. Without a full year, a low January would read as a decline. With a full year, it reads as a season.
Strength of evidence: provisional. One winter is one observation. Your second Annual Review will be the first document that can test it, because it will hold two.
The one finding this document cannot make
There is no year-over-year comparison here. This is your first year, so there is nothing to compare it against. That section will appear in your next Annual Review and it does not exist in this one — I would rather show you an honest gap than a placeholder.
Year-2 Forward Plan
Four priorities for your second year, each with the specific thing that would tell us it worked.
1. Test whether the seasonal floor is real
Your second winter is the first genuine test of finding 3. The question is whether January 2026 looks like January 2025 in activity terms, and whether your sleep and recovery hold through it as they did through December.
2. Protect the early-warning signal
Your sleep duration moves before everything else. The priority is not just maintaining it, but treating a drop in it as information rather than an inconvenience. Practically: two consecutive cycles below 7.0 hours is worth a conversation with your physician team, not a wait-and-see.
3. Hold the travel recovery window at two days
You have gone from five days to two. Holding a gain is a different task from making one, and the year in which people give back their improvements is usually the second. The specific test is your first two trips of Year 2.
4. Re-establish the load–recovery link with two devices
You now have a full year of Garmin activity data alongside Oura recovery data. Your Year 2 reports will begin reading them against each other — the running volume Garmin sees against the recovery Oura sees — which is a relationship your first year could only approximate.
Research Foundation Reference
The mechanism explanations in this Review — the relationship between sleep opportunity and overnight heart rate variability, the physiology of recovery following travel and circadian disruption, and the limitations of consumer sleep-stage detection relative to polysomnography — are grounded in the maintained WWG Research Foundation bibliography, which is the sole source of research citation across all WWG reports.
How AI Was Used in This Review
Artificial intelligence is used in preparing this report to organise and compute — never to interpret. It assembles your data, calculates trends and comparisons against your own baseline, and produces a provisional data-quality grade for a physician to confirm or override. It does not write clinical judgement. No AI-drafted text is presented to you as your physician's voice. Every interpretation, every recommendation, and every word of the clinical narrative in this report was written by a named physician.
| In this Review | Computed by AI | Reviewed by physician | Authored by physician |
|---|---|---|---|
| 12-month data pre-aggregation | Yes | Confirmed | — |
| Baseline Evolution sparklines | Chart pipeline | Accuracy confirmed | — |
| Recommendation Retrospective — data assembly | Yes | Confirmed | — |
| “What Only a Year Reveals” — candidate detection | Flags candidates only | Medical Director determines genuine longitudinal significance | — |
| Year-in-Health Narrative | Never | — | 100 % Medical Director, non-delegable |
| Retrospective analysis | No | — | Medical Director |
| Year-2 Forward Plan | No | — | Medical Director & Care Team |
| Full-year trajectory synthesis | No | — | Physician |
Signature Block
Consolidated Provider Summary
Fifty-two consecutive weeks of consumer wearable data, physician-reviewed every week, with quarterly physician synthesis. All comparisons are against the subscriber's own baseline (weeks 1–4), not population norms.
| Metric | Baseline (wk 1–4) | Week 52 | Year mean | Q1 → Q4 |
|---|---|---|---|---|
| HRV (overnight, Oura) | 48.0 ms | 56 ms | 50.8 ms | 46.4 → 54.9 |
| Resting HR | 56 bpm | 51 bpm | 53.8 bpm | 56.6 → 51.5 |
| Sleep duration | 7.2 h | 7.7 h | 7.4 h | 7.0 → 7.7 |
| Sleep efficiency | 90 % | 93 % | 91.0 % | 88.8 → 92.9 |
| Steps | 8,700/day | 10,100/day | 9,580/day | 8,880 → 10,110 |
Course of the year
Stable establishment (weeks 1–4). Transient decline weeks 9–11 coinciding with a documented high-workload period and concurrent increase in recreational running volume (HRV nadir 42 ms, sleep nadir 6.3 h), fully resolved by week 13 following a self-implemented reduction in training volume. Progressive improvement across all five tracked metrics from Q2 onward, sustained through Q4. Ten discrete short-duration declines across the year coincide with documented business travel; the recovery interval associated with these declined from approximately 5 days (February) to approximately 2 days (December).
No abnormality flagged in any of the 52 cycles. No symptom report. One Worth Watching designation (week 6), resolved by week 8. No escalation to Needs Follow-Up at any point in the year. No device-flagged rhythm data exists for this subscriber, and no waveform interpretation has been performed.
Data quality
94 % overnight wear compliance across 365 nights; 4 cycles carry partial-wear caveats. HRV, resting heart rate and step data are reliable and may be read at face value. Sleep-efficiency data should be read directionally only — consumer sleep-stage detection is not equivalent to polysomnography. Oura was retained as the sole HRV source for all 52 cycles to preserve baseline comparability; Garmin overnight HRV ran 6–9 ms lower owing to differing sampling methodology and was not merged into the HRV series.
Scope
Wellness monitoring only. No diagnosis has been made, no treatment or medication guidance given, and no referral issued. This summary is offered as twelve months of longitudinal context for your own assessment, not as a clinical finding.
Looking Ahead
Your Year 2 begins at cycle 53. Your weekly, monthly and quarterly reports continue exactly as before.
One thing changes. Your next Annual Review, twelve months from now, will carry a section this one could not: a year-over-year comparison. It will place your 2026 against your 2025 and answer the only question this document has to leave open — whether a good year was a change or a moment.